Changeflow GovPing Pharma & Drug Safety Surface-Modified Viral Particles and Modular Vi...
Routine Notice Added Final

Surface-Modified Viral Particles and Modular Viral Particles Patent Application

Favicon for changeflow.com USPTO Patent Applications - Peptides (C07K)
Published
Detected
Email

Summary

USPTO published patent application US20260098280A1 for surface-modified viral particles and modular viral particles (anellovectors and anelloVLPs) filed December 8, 2025. The application names five inventors including Simon Delagrave, Kurt Adam Swanson, and Noah Robert Cohen. CPC classifications include C12N 15/86 and C07K 14/005.

What changed

USPTO published patent application US20260098280A1 covering surface-modified viral particles and modular viral particles including anellovectors and anelloVLPs. The application was filed December 8, 2025, under Application No. 19411905 with five inventors. CPC classifications indicate biotechnological applications in the C12N and C07K patent classes.

For biotech and pharmaceutical companies developing viral vector delivery systems, gene therapies, or vaccine technologies, this published application represents potential prior art. Competitors should assess whether the claimed compositions or methods overlap with their own R&D programs and consider filing observations during the examination period.

What to do next

  1. Monitor patent prosecution for grant or rejection
  2. Review claims for potential licensing opportunities
  3. Assess freedom-to-operate implications for viral vector work

Archived snapshot

Apr 10, 2026

GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.

← USPTO Patent Applications

SURFACE-MODIFIED VIRAL PARTICLES AND MODULAR VIRAL PARTICLES

Application US20260098280A1 Kind: A1 Apr 09, 2026

Inventors

Simon Delagrave, Kurt Adam Swanson, Noah Robert Cohen, Shu-Hao Liou, Amir Khan

Abstract

This invention relates generally to anellovectors, anelloVLPs, and compositions and uses thereof.

CPC Classifications

C12N 15/86 C07K 14/005 C12N 7/00 C12N 2750/00022 C12N 2750/00023 C12N 2750/00043 C12N 2750/00051

Filing Date

2025-12-08

Application No.

19411905

View original document →

Get daily alerts for USPTO Patent Applications - Peptides (C07K)

Daily digest delivered to your inbox.

Free. Unsubscribe anytime.

About this page

What is GovPing?

Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission

What's from the agency?

Source document text, dates, docket IDs, and authority are extracted directly from USPTO.

What's AI-generated?

The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.

Last updated

Classification

Agency
USPTO
Published
April 9th, 2026
Instrument
Notice
Legal weight
Non-binding
Stage
Final
Change scope
Minor
Document ID
US20260098280A1

Who this affects

Applies to
Pharmaceutical companies Manufacturers Healthcare providers
Industry sector
3254.1 Biotechnology
Activity scope
Patent filing Biotechnology research Gene therapy development
Geographic scope
United States US

Taxonomy

Primary area
Intellectual Property
Operational domain
Legal
Topics
Biotechnology Pharmaceuticals

Get alerts for this source

We'll email you when USPTO Patent Applications - Peptides (C07K) publishes new changes.

Free. Unsubscribe anytime.

You're subscribed!